Collaborative research helps long-COVID patients recover In the NIH Directors Blog posted on Wednesday, Dr. Gary Gibbons of the National Heart, Lung, and Blood Institute writes about a National Institutes of Health (NIH) initiative, Researching COVID to Enhance Recovery (RECOVER).Read More
Rare cancer study identifies patients at high risk of metastasis A large genomic study of a rare cancer called metastatic pheochromocytoma identified patients at high risk of metastasis, as well as those most likely to respond to immunotherapy. The results, published in Nature Communications on February 28, may allow closer following up of patients with poor prognoses, and facilitate more personalized treatments.Read More
Plugging immune cell leakage may improve melanoma treatment NYU Langone Health researchers found in a study that the number of specialized immune cells available for fighting skin cancer doubled when a new treatment blocked their escape from melanoma tumors. The study, published February 27 in Nature Immunology, found that combining an immune cell exit blocker with another immunotherapy drug stopped melanoma tumor enlargement in more than half of the mice tested.Read More